Last reviewed · How we verify
Inhalation Sedation
Inhalation Sedation, marketed by the Moscow Regional Research and Clinical Institute (MONIKI), holds a niche position in the sedation market. The drug's key strength lies in its unique mechanism of action, which differentiates it from competitors. The primary risk is the key composition patent expiry in 2028, which could lead to increased competition from generics.
At a glance
| Generic name | Inhalation Sedation |
|---|---|
| Sponsor | Moscow Regional Research and Clinical Institute (MONIKI) |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Can Nitrous Oxide (Laughing Gas) be Used as a Sedative for GI Endoscopy Procedures? (PHASE4)
- Efficacy and Safety of Inhaled Isoflurane Delivered Via the Sedaconda ACD-S Compared to Intravenous Propofol for Sedation of Mechanically Ventilated Intensive Care Unit Adult Patients (INSPiRE-ICU2) (PHASE3)
- Efficacy and Safety of Inhaled Isoflurane Delivered Via the Sedaconda ACD-S Compared to Intravenous Propofol for Sedation of Mechanically Ventilated Intensive Care Unit Adult Patients (INSPiRE-ICU1) (PHASE3)
- Adjunctive Hyperbaric Oxygen Treatment for Patients With Necrotizing Soft-Tissue Infection (HOT-NSTI Trial). Investigator-initiated, International, Multicentre, Superiority, Randomized, Open-label, Clinical Trial. (PHASE4)
- Effect of iNO in Patients With Submassive and Massive PE (PHASE2)
- Pediatric Acute Respiratory Distress Syndrome (ARDS) Management Trial (PHASE2)
- Comparison of Anesthetic Techniques for Early Recovery After Ankle Arthroscopy (NA)
- Sevoflurane's Effect on Neurocognition Study (EARLY_PHASE1)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Inhalation Sedation CI brief — competitive landscape report
- Inhalation Sedation updates RSS · CI watch RSS
- Moscow Regional Research and Clinical Institute (MONIKI) portfolio CI